These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
295 related articles for article (PubMed ID: 31006114)
1. Haloperidol discontinuation for people with schizophrenia. Essali A; Turkmani K; Aboudamaah S; AbouDamaah A; Diaa Aldeen MR; Marwa ME; AlMounayer N Cochrane Database Syst Rev; 2019 Apr; 4(4):CD011408. PubMed ID: 31006114 [TBL] [Abstract][Full Text] [Related]
2. Clozapine combined with different antipsychotic drugs for treatment-resistant schizophrenia. Barber S; Olotu U; Corsi M; Cipriani A Cochrane Database Syst Rev; 2017 Mar; 3(3):CD006324. PubMed ID: 28333365 [TBL] [Abstract][Full Text] [Related]
3. Haloperidol versus placebo for schizophrenia. Adams CE; Bergman H; Irving CB; Lawrie S Cochrane Database Syst Rev; 2013 Nov; (11):CD003082. PubMed ID: 24242360 [TBL] [Abstract][Full Text] [Related]
4. Haloperidol (oral) versus olanzapine (oral) for people with schizophrenia and schizophrenia-spectrum disorders. Ibragimov K; Keane GP; Carreño Glaría C; Cheng J; Llosa AE Cochrane Database Syst Rev; 2024 Jul; 7(7):CD013425. PubMed ID: 38958149 [TBL] [Abstract][Full Text] [Related]
5. Haloperidol versus first-generation antipsychotics for the treatment of schizophrenia and other psychotic disorders. Dold M; Samara MT; Li C; Tardy M; Leucht S Cochrane Database Syst Rev; 2015 Jan; 1(1):CD009831. PubMed ID: 25592299 [TBL] [Abstract][Full Text] [Related]